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Skp2Cullin-RING ubiquitin (Ub) ligases (CRLs) are responsible for ubiquitinylation of approximately 20% of all
proteins degraded by the Ub proteasome system (UPS). CRLs are regulated by the COP9 signalosome (CSN)
and by Cullin-associated Nedd8-dissociated protein 1 (CAND1). The CSN is responsible for removal of
Nedd8 from cullins inactivating CRLs. CAND1 modulates the assembly of F-box proteins into cullin 1–RING
Ub ligases (CRL1s). We show that CAND1 preferentially blocks the integration of Skp2 into CRL1s. Suppres-
sion of CAND1 expression in HeLa cells leads to an increase of the Skp2 assembly into CRL1s and to signiﬁcant
reduction of the cyclin-dependent kinase (CDK) inhibitor p27. In contrary, CAND1 overexpression causes
elevation of p27. The observed CAND1-dependent effects and CAND1 expression are independent of the
CSN as demonstrated in CSN1 knockdown cells. Increase of p27 is a hallmark of preadipocyte differentiation
to adipocytes (adipogenesis). We demonstrate that the accumulation of p27 is associated with an increase of
CAND1 and a decrease of Skp2 during adipogenesis of human LiSa-2 preadipocytes. CAND1 knockdown
reduces p27 and blocks adipogenesis. Due to the impact of CAND1 on Skp2 control, CAND1 could represent
an important effector molecule in adipogenesis, but also in cancer development.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The Ub ligases, E3s, play a pivotal role in the UPS, because they con-
fer substrate speciﬁcity to intracellular proteolysis [1]. Members of the
cullin family (Cul1, Cul2, Cul3, Cul4A, Cul4B, Cul5, Cul7, PARC and
APC2) provide the scaffold of CRL complexes responsible for a large
portion of UPS-mediated proteolysis. The C-terminus of the cullin
binds a RING H2 ﬁnger protein, Rbx1 or Rbx2, which recruits the E2
with the activated Ub. The N-termini of cullins bind substrate–adaptor
proteins (Skp1, elongin C or DDB1) that recruit substrate-recognition
subunits (SRSs) to the complex [2].
F-box proteins (FBP) function as SRS in case of Cul1 complexes
(CRL1) [2,3]. They can be subdivided into 3 groups: FBPs with WD40
domain (FBXWs) including β-TrCP and Fbxw7, FBPs with leucine-rich
repeats (FBXLs) such as Skp2 and FBPs with other diverse domains
(FBXOs) [4]. β-TrCP targets regulators of cell cycle or apoptosis for
ubiquitinylation. It binds speciﬁcally phosphorylated IκBα, β-catenin,
PDCD4 and CDC25A [5] and is an oncoprotein because it targets tumor
suppressors such as PDCD4. Fbxw7 recognizes its substrates also via a
phospho-degron that is present in proto-oncogenes such as c-Myc,
N-Myc, c-Jun, but also in Notch, cyclin E1 and SREBP1. These substrates
are implicated in proliferation and oncogenesis but also in brain devel-
opment and neurogenesis [6,7]. Skp2 is a high abundant FBP [8] and: +49 30 450522928.
l rights reserved.involved in the regulation of cell cycle by targeting CDK inhibitors p21
and p27 [5]. Skp2 recognizes p27 upon CDK-mediated phosphorylation
on Thr187. It is an oncogene and increase of Skp2 expression was
observed in a wide range of human tumors [5]. Skp2 regulates entry
into S phase by mediating the degradation of p27. It becomes unstable
in G1 after ubiquitinylation by the anaphase-promoting complex/
cyclosome (APC/C) [9]. Typically the abundance of integrated FBPs is
regulated by autoubiquitinylation within the CRL1 complex. Knock-
down of the CSN subunit 5 (CSN5) and suppression of CSN-mediated
removal of Nedd8 (deneddylation) reduce FBP levels in human cells
[10,11] indicating that a major function of the CSN is the protection of
FBPs against degradation [10–12].
CSN and CAND1 are essential regulators of CRLs in eukaryotic cells.
Interestingly, both regulators inhibit CRL activities in vitro but pro-
mote CRL functions in vivo [11,13]. In mammals the CSN consists of
8 subunits (CSN1–8) [14] and exhibits an intrinsic metalloprotease
activity mapped to the MPN+/JAMM motif of CSN5 [15]. This activity
is responsible for the removal of the Ub-like protein Nedd8 from
cullins [16,17]. Recent studies demonstrated a signiﬁcant confor-
mational change of CRL1Skp2 upon Nedd8 conjugation [18]. The
neddylated form of the CRL1Skp2 allows the initiator Ub to bridge a
50 Å gap between E2 and the substrate [2] and therefore neddylation
accelerates the process of ubiquitinylation [19] and, accordingly,
deneddylation inhibits CRLs. Hence CSN-mediated deneddylation
prevents autoubiquitinylation and degradation of FBPs [11]. Interest-
ingly, CSN containing mutant CSN5 still efﬁciently protects FBPs
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function [12]. In the presence of a speciﬁc substrate the CSN is per-
haps released from the CRL1 until the substrate is completely
ubiquitinylated and degraded [20,21].
In addition, the CSN is associated with a variety of proteins includ-
ing protein kinases [22–24] and the Ub-speciﬁc protease, USP15, a
deubiquitinylating enzyme, which protects non-FBPs proteins against
autoubiquitinylation and degradation [11,25–30].
CAND1 speciﬁcally binds to free, unneddylated cullin-Rbx com-
plexes. The C-terminus of CAND1 blocks the substrate adaptor/SRS
site of Cul1, whereas the N-terminus binds directly the Nedd8 accep-
tor lysine of Cul1 preventing neddylation [31]. It has been shown that
the Skp1–Skp2 complex abrogates the inhibitory effect of CAND1 and
in the presence of the substrate p27 an active, neddylated CRL1Skp2
complex can be formed [32]. It seems that CAND1 does not function
by sequestering all cullins and protecting CRL components, since
only a small portion of unneddylated Cul1 is associated with CAND1
in cells [33]. On the other hand, CAND1 deletion leads to developmen-
tal defects in Aspergillus nidulans [34] and Caenorhabditis elegans [35],
where it seems to be required for the activity of distinct CRLs. More-
over, in Schizosaccharomyces pombe CAND1 helps rare FBPs to be inte-
grated into CRLs [11].
Here we demonstrate that CAND1 differentially inﬂuences the
integration of the FBPs into CRL1 complexes. Suppression of CAND1
expression speciﬁcally promotes the incorporation of Skp2 into CRL1
complexes accompanied with a degradation of p27. The function of
CAND1 is essential for the differentiation of human LiSa-2 preadipocytes,
and suppression of CAND1 expression abrogates adipogenesis.
2. Materials and methods
2.1. Cell culture, cell differentiation
HeLa cells and Flag-CSN2 B8 mouse ﬁbroblasts were cultured under
standard conditions [36] and lysed with ice-cold triple-detergent lysis
buffer (50 mM Tris–HCl, pH 8.5, 150 mM NaCl, 0.02% (w/v) sodium
azide, 0.1% (w/v) SDS, 1% (v/v) NP-40, 0.5% (w/v) sodiumdeoxycholate)
with freshly added PMSF (1 mg/ml) and aprotinin (10 μg/ml). We used
human liposarcoma cells (LiSa-2) to study adipocyte differentiation in
vitro. LiSa-2 cells were grown in Iscove/RPMI 4:1 with 10% fetal calf
serum (FCS; Biochrom, Berlin, Germany), 100 U/ml penicillin and
0.1 mg/ml streptomycin or serum-free, basal medium (DMEM/F12
(1:1)) supplemented with 10 mg/ml transferin, 15 mM NaHCO3,
15 mMHEPES, 33 mMbiotin, 17 mMpantothenate, 100 U/ml penicillin
and 0.1 mg/ml streptomycin. To induce differentiation of conﬂuent
LiSa-2 cells, cells were cultured in serum-free medium supplemented
with 1 nM insulin, 20 pM triiodthyronine and 1 mM cortisol
(adipogenic medium). LiSa-2 cells were plated on a 6-well-plate and
cultured for 24 h with Iscove/RPMI medium. During differentiation
the medium was changed every other day. Differentiation was moni-
tored by a protocol described before [37,38] and assessed by Oil Red O
(ORO) staining using the Thermo Scientiﬁc HyClone complete
AdvanceSTEM™ Adipogenic differentiation kit (Thermo Fisher Scientif-
ic, Schwerte, Germany). In this protocol provided by the manufacturer
lipid droplets are stainedwith ORO and nucleiwith hematoxylin. Differ-
entiated cells were harvested after indicated days of differentiation and
lysed using triple-detergent lysis buffer. ORO was quantiﬁed according
to [39]. In brief, after washing cells four times in PBS, the ORO stained
lipids were extractedwith 4% NP-40 and 96% isopropanol. The superna-
tants were measured spectrophotometrically at 520 nm.
2.2. siRNA knockdowns and transient transfections
HeLa cells permanently downregulating CSN1 (siCSN1 cells) or CSN5
(siCSN5 cells) were produced as described [40,41]. For transient trans-
fection cells were transfected with 50, 100 or 150 nM of siRNA againstCAND1 (Eurogentec) or against control siGFP using Lipofectamine 2000
(Invitrogen). 24 h after transfection cells were lysed and supernatants
were analyzed by SDS-PAGE and Western blotting. CAND1
overexpression was performed with 3xmyc-CAND1 (Addgene)
and indicated DNA amounts using Lipofectamine 2000.
2.3. Immunoprecipitation, Flag-pulldowns, glycerol gradients, Western
blotting and statistics
Immunoprecipitations with the anti-CSN7 and the anti-CAND1
antibodies were carried out as described [41]. Flag-pulldowns using
Flag-CSN2 B8 cells were outlined before [36]. Just in brief, lysates
were loaded onto the prepared ANTI-FLAG M2 afﬁnity column
(Sigma). After washing with 20 column volumes of 1 x TBS (50 mm
Tris–HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA), proteins were eluted
by competition with the Flag peptide (100 μg/ml) as recommended
by the manufacturer (Sigma). Eluted proteins were used for Western
blots. Glycerol gradient centrifugation analysis was performed as
described [38]. Fractions with different density (5% to 22% glycerol)
were analyzed by Western blots. Density gradient was calibrated
with puriﬁed CSN (about 400 kDa, fractions 5–7) and with puriﬁed
20S proteasome (about 700 kDa, fractions 8–9). Proteins were sepa-
rated and analyzed by SDS-PAGE and Western blotting using anti-
bodies against Cul1, γ-tubulin, CAND1, Fbxw7, c-Jun, c-Myc, Skp2,
p27, β-TrCP, β-catenin and PPAR-γ (all antibodies from Santa Cruz).
Densitometry was carried out applying the ImageJ software. Statistics
were calculated with Microsoft Excell and with GraphPad InStat3 soft-
ware. Error bars are standard deviations (SD) or standard error of mean
(SEM) and unpaired Student's t-test was used for statistical analysis.
3. Results
3.1. CAND1 regulates Skp2 integration into CRL1s and p27 degradation
Based on the hypothesis that in the presence of the CSN and the
speciﬁc substrate FBPs are stabilized by integration into CRL1 com-
plexes and that CAND1 modulates their integration [11], we studied
CAND1-dependent FBP steady state levels. Moreover, the function of
the FBPs Fbxw7, Skp2 and β-TrCP was investigated by estimating
steady state levels of their typical substrates c-Myc, p27 as well as
β-catenin, respectively. To study a possible functional cooperation
between CAND1 and the CSN, and the impact on the assembly of
CRL1 complexes we used HeLa cells permanently expressing siRNA
against CSN1 (siCSN1 cells). siCSN1 cells [42] are characterized by re-
duced CSN1 protein steady state level, which is connectedwith approx-
imately 60% reduction of the whole CSN complex [40,42] and a slight
reduction of total FBPs (Fig. 1A) conﬁrming earlier observations [10,11].
First, CAND1 expression was transiently suppressed by transfecting
50, 100 or 150 nM siCAND1 into siCSN1 cells, or appropriate control
cells permanently expressing siRNA against GFP (siGFP cells). Treat-
ment of the cells with 150 nM siCAND1 led to suppression of CAND1
protein levels by more than 70% (Fig. 1A and B). As a consequence of
CAND1 knockdown a signiﬁcant increase of Skp2 expression in siGFP
cells as well as in siCSN1 cells was observed (Fig. 1A and B). Quantiﬁca-
tion of Skp2 showed that the protein amount increased more than
2-fold in siGFP and in siCSN1 cells suggesting an enhanced incorpora-
tion into CRL1 complexes. The assumption about the enhanced integra-
tion of Skp2 into CRL1 was supported by a signiﬁcant reduction of the
Skp2 substrate p27 (Fig. 1A and B). Steady state levels of p27 were
reduced in siGFP as well as in siCSN1 cells by approximately 70% upon
downregulation of CAND1. In contrast, there was neither a signiﬁcant
change of Fbxw7 or of β-TrCP nor of their substrates c-Myc or
β-catenin as a consequence of CAND1 knockdown (Fig. 1A). In most of
the cases 50 nM of CAND1 siRNA were sufﬁcient for suppression of
CAND1 expression (Fig. 1A), but all calculations were carried out
with 150 nM of siCAND1. Similar data as shown here for CAND1
Fig. 1. CAND1 knockdown stabilizes Skp2 and reduces p27. (A) siGFP cells or siCSN1
cells were transfected with 50, 100 and 150 nM siGFP (control) or siCAND1. After
24 h cells were lysed and proteins analyzed by Western blotting using indicated anti-
bodies. (B) Blots as shown in (A) of CAND1 (n=4), Skp2 (n=3) and p27 (n=3) were
quantiﬁed by densitometry, normalized against γ-tubulin and expressed as means of
relative amounts. Quantiﬁcations were carried out for 150 nM of siGFP or siCAND1.
Error bars are standard deviations (SD). Unpaired Student's t-test was used for statis-
tical analysis. *Pb0.05, **Pb0.01, ***Pb0.005.
Fig. 2. Incorporation of Skp2 into large complexes upon CAND1 downregulation.
(A) HeLa cells were transfected with siGFP. 24 h after transfection cells were lysed
and lysates loaded on glycerol density gradients. Fractions with different density
were analyzed by Western blots using antibodies against CAND1, Cul1, Skp2, p27
and CSN8. The density gradient was calibrated with puriﬁed CSN (approximately
400 kDa) and puriﬁed 20S proteasome (approximately 700 kDa). (B) HeLa cells were
transfected with siCAND1 and 24 h later glycerol density gradient centrifugation and
Western blots were performed as in (A). (C) Flag-CSN2 B8 cells were transfected
with 100 nM siGFP (control) or siCAND1. After 24 h cells were lysed and proteins of
lysate and Flag-pulldown analyzed by Western blotting using indicated antibodies.
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not shown).
To verify the impact of CAND1 on the integration of Skp2 into
CRL1 complexes we used for additional studies density gradient cen-
trifugation after treatment of HeLa cells with 100 nM of CAND1
siRNA. After 24 h cells were lysed and cellular proteins were separat-
ed by density gradients and analyzed by Western blotting. As shown
in Fig. 2 knockdown of CAND1 led to a shift of Skp2 from fractions
with low density (Fig. 2A, fractions 2–4) into fractions with higher
density (Fig. 2B, fractions 5–7). Obviously Skp2 was integrated into
larger complexes, most likely CRL1s responsible for the promotion
of p27 degradation. The presence of both Cul1 and Skp2 in the same
fractions reﬂects the assembled CRL1 complexes which peak in
CAND1 knockdown cells. The anti-CSN8 antibody marks the position
of the CSN complex. Density gradients were calibrated with puriﬁed
CSN and 20S proteasome.
To visualize increased incorporation of Skp2 into CRL1 complexes
after CAND1 silencing more speciﬁcally, we performed Flag-pulldowns.
Flag-CSN2-B8 ﬁbroblasts [36] were transfected with siCAND1 or siGFP
and after 24 h cells were lysed and Flag-pulldowns and subsequent
Western blotswere carried out. As seen in Fig. 2C, CAND1downregulation
led to a reduction of CAND1 protein to less than 50%. The Flag-pulldown
precipitated the CSN complex as demonstrated by the anti-CSN6 antibody
together with CRL1 complex indicated by Cul1. There was an increasedSkp2 incorporation into the CRL1 complex upon CAND1 silencing as dem-
onstrated by the anti-Skp2 antibody (Fig. 2C).
Although ectopic expression of CAND1 was not very efﬁcient, there
was an approximately 2.5-fold increase of p27 caused by CAND1
overexpression in siGFP as well as siCSN1 cells (Fig. 3A and B). This
was not reﬂected by a signiﬁcant decrease of Skp2 steady state levels.
Fbxw7 and β-TrCP also did not change upon CAND1 overexpression.
3.2. CAND1 does not interact with the CSN
For better understanding the interplay between CAND1, CSN and
CRLs we carried out protein-protein interaction studies. To investi-
gate physical interaction of CAND1 with the CSN we performed
Flag-pulldowns as in Fig. 2C using Flag-CSN2 stable transfected B8
ﬁbroblasts [36] upon CAND1 overexpression. Herein, we found no
detectable CAND1/CSN interaction in the Flag-pulldowns. Further,
overexpression of CAND1 had no impact on CSN binding to Cul1
(Fig. 4A). The CSN becomes assembled in supercomplexes with CRLs
Fig. 3. Overexpression of CAND1 stabilizes p27. (A) siGFP cells or siCSN1 cells were
transfected with 8 or 12 μg of control (3xmyc-vector) or 3xmyc-CAND1. After 24 h
cells were lysed and Western blots were carried out with indicated antibodies.
(B) Quantiﬁcations of p27 were carried out from the results of cells transfected with
12 μg 3xmyc-vector or 3xmyc-CAND1 from three independent experiments as shown
in (A). Data were normalized against γ-tubulin and expressed as mean % p27±SD.
Unpaired Student's t-test was used for statistical analysis and statistical signiﬁcance is
indicated as: *Pb0.05, ***Pb0.005.
Fig. 4. CAND1 does not interact with the CSN. (A) Flag-CSN2 B8 ﬁbroblasts were
transfected with 70 μg 3xmyc-CAND1. After 36 h Western blots were performed
from lysates (left panel) or Flag-pulldowns (right panel) using antibodies against
CAND1, Cul1, CSN5 and CSN6. CAND1 was not detectable in the Flag-CSN2 pulldown
of the CSN. There was no impact of 3xmyc-CAND1 overexpression on CSN binding to
Cul1. (B) The CSN was immunoprecipitated with anti-CSN7 antibody and CAND1
with a speciﬁc anti-CAND1 antibody. There was no CAND1 in the immunoprecipitate
of the CSN and no CSN5 in the precipitate of CAND1 detectable.
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previous data [27] and data from other groups [43,44] indicate that
the CSN interacts with all cullins of all studied CRLs, and also
CAND1 interacts with all cullins in human cells [33]. Therefore we
asked whether the CSN and CAND1 co-immunoprecipitate. Using
the anti-CSN7 antibody which precipitates the entire CSN complex
and associated proteins [22] we could not recognize CAND1 in the
precipitate (Fig. 4B), which conﬁrms earlier studies [45,46]. More-
over, immunoprecipitation with an anti-CAND1 antibody did not pre-
cipitate the CSN (Fig. 4B).
3.3. CAND1 is essential for adipogenesis
CAND1 deletions in C. elegans and in A. nidulans led to severe
developmental phenotypes [34,35]. Recently we found that the CSN,
another regulator of CRLs, promotes the differentiation of LiSa-2
preadipocytes to adipocytes (adipogenesis) [38]. Therefore, we were
interested to address the impact of CAND1 on adipogenesis. For this
purpose LiSa-2 preadipocytes were stimulated by insulin, cortisol
and triiodthyronine and incubated for 22 days. At days 1, 8, 15 and
22 cells were lysed and investigated by Western blotting. As shown
in Fig. 5A and B an increase of CAND1 during adipogenesis wasobserved. The amount of CAND1 was elevated more than 2-fold at
day 22. Concomitant with the increase of CAND1, there was a slight
decrease of Skp2 and a signiﬁcant increase of p27 starting from day
eight of adipogenesis observed (Fig. 5A and B). Cul1 and the ratio
between neddylated and unneddylated Cul1 did not change. The nu-
clear hormone receptor peroxisome proliferator-activated receptor γ
(PPARγ) acts as a master switch in adipocyte differentiation. It is
degraded by the UPS [47,48]. In our experiments (Fig. 5A) PPARγ in-
creased about 4-fold on day 22. Changes of Fbxw7 and β-TrCP were
not detected and c-Jun and β-catenin decreased only marginally.
CAND1 was essential for the differentiation of LiSa-2 preadipocytes.
This was demonstrated by transient transfection of 100 nM siCAND1
48 h prior to induction of differentiation (Fig. 6). As shown before in
HeLa cells CAND1 knockdown led to a signiﬁcant reduction of CAND1
steady state levels after 1 day of differentiation (corresponding to
3 days after transfection) and after 3 days of differentiation (corre-
sponding to 5 days after transfection). After 8 days of differentiation
and 10 days of transfection, CAND1 levels in siCAND1 treated cells
recovered to almost control values. Nevertheless, suppression of
CAND1 expression for 3 and 8 days led to a signiﬁcant effect on cell dif-
ferentiation. As shown by quantiﬁcation of ORO staining lipids accumu-
lated in control cells transfected with control siGFP as a hallmark of
normal adipocyte differentiation. In contrast, CAND1 silencing led to a
signiﬁcant reduction of ORO staining by approximately 30% after
Fig. 5. CAND1 becomes upregulated during differentiation of LiSa-2 preadipocytes and
stabilizes p27. (A) Western blot analysis of cells prepared on day 1, 8, 15 and 22 after
induction of adipogenesis were carried out using indicated antibodies. Unneddylated
(Cul1) and neddylated (Nedd8–Cul1) are speciﬁcally indicated. There is an increase
of CAND1 and of p27, whereas Fbxw7 and β-TrCP did not change, while Skp2 declines.
(B) CAND1, Skp2 and p27 data were quantiﬁed by densitometry, normalized against
γ-tubulin and plotted as relative change against days of adipogenesis. Error bars are
standard deviations of 3 independent experiments. Unpaired Student's t-test revealed
statistical signiﬁcance between 1 day and 22 days of CAND1 steady state levels
(*Pb0.05) and between 1 day and 22 days of p27 levels (*Pb0.05).
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croscopy images nicely demonstrate reduced lipid droplet formation in
particular after 8 days as a consequence of CAND1 knockdown (Fig. 6C).
4. Discussion
Our data demonstrate that CAND1 knockdown in studied human
cells signiﬁcantly increases the integration of the FBP Skp2 into
CRL1 complexes. This is shown by stabilization of Skp2 steady state
levels as well as by enhanced degradation of p27, a substrate of
CRL1Skp2 Ub ligase [5]. We hypothesize that the integration of Skp2
into CRL1 complex upon CAND1 silencing occurs under the protectionof the CSN and results in a stabilization of Skp2. Even in our siCSN1
cells inwhich the total FBPs are reduced conﬁrming earlier observations
[10–12], we did detect a protection/stabilization of Skp2. Nevertheless,
we cannot exclude an induction of Skp2 expression upon CAND1
downregulation. Our experiments using density gradients showed the
shift of Skp2 to large complexes, most likely CRL1Skp2 complexes,
upon suppression of CAND1 expression. Moreover, pulldowns of
Flag-CSN-CRL1 complexes revealed an increase of Skp2 incorporation
into CRL1 complexes upon silencing of CAND1.
There was no effect of CAND1 knockdown neither on the stability of
Fbxw7 or β-TrCP, nor on the degradation of c-Myc or β-catenin. These
data demonstrate a preferential effect of CAND1 on Skp2 integration.
In contrast to the knockdown, overexpression of CAND1 signiﬁcantly
stimulated steady state levels of p27, although Skp2 did not change
signiﬁcantly. This might be due to a quick recovery of control Skp2
steady state levels after CAND1 overexpression. Again, no inﬂuence
was observed on Fbxw7 and β-TrCP upon CAND1 overexpression.
Interestingly, there was no dependency between CAND1 and the
CSN observed, thus, CAND1 acts independently of the CSN on CRLs.
This was also shown by CAND1 overexpression and subsequent CSN
pulldowns in Flag-CSN2 B8 mouse ﬁbroblasts (Fig. 4A). Further,
there was no competition between CAND1 and the CSN for binding
to Cul1 recognized. The absence of CAND1 in immunoprecipitates of
the CSN (Fig. 4) conﬁrms most of the earlier results [45,46] with the
exception of pulldowns from human T cells showing CAND1 in CSN
precipitates [49], which might be mediated by additional proteins.
Our data support the notion of CAND1 as a regulator of CRL
assembly [50] that differentially affects the composition of CRL1
complexes [11]. We conclude that it acts as an inhibitor of the inte-
gration of the highly abundant Skp2 into CRLs. The exact mechanism
how CAND1 speciﬁcally blocks the incorporation of Skp2 into CRL1
complexes is not known at the moment. Herein, the fact that the
Skp2–Skp1 dimer is unable to inhibit CSN-mediated deneddylation
in contrast to the β-TrCP–Skp1 and Fbxw7–Skp1 dimers might be
important [21].
Because CAND1 stabilizes p27, it could act as a tumor suppressor. In-
terestingly, its suppression has been reported in lung tumors [51] and
accelerated degradation of p27 is a hallmark of many tumor cells [5].
p27 is an important regulator of cell differentiation. Accumulation
of p27 causes cell cycle exit necessary for the erythroid differentiation
[52]. During 3T3-L1 preadipocyte differentiation the exit from the cell
cycle into a pre-differentiation state of post-mitotic growth arrest
was characterized by signiﬁcant increase in p27. Interestingly this
increase of p27 was predominantly independent of gene expression
occurring via unknown post-transcriptionally controlled pathways
[53]. Here we show for the ﬁrst time that CAND1 is an essential reg-
ulator of adipogenesis, since it protects p27 against Ub-dependent
degradation. However, we cannot exclude that CAND1 regulates
other factors in addition to p27. CAND1 increases during differentia-
tion of LiSa-2 preadipocytes and in parallel the p27 steady state
amounts. This effect is presumably due to the CAND1 blockade of
the integration of Skp2 into CRL1 complexes. Therefore, CAND1
knockdown reduces p27 and leads to inhibition of adipogenesis as
measured by reduced lipid droplet formation. These experiments
demonstrate that CAND1 is essential for LiSa-2 preadipocyte differen-
tiation. Because of its high preference for Skp2 inactivation, CAND1
could represent an important factor in adipogenesis and in cancer de-
velopment. Therefore, CAND1 is a distinguished target for the treat-
ment of obesity and of different types of cancer.Acknowledgments
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Fig. 6. CAND1 knockdown leads to blockade of LiSa-2 preadipocyte differentiation. (A) LiSa-2 cells were transiently transfected with 100 nM siGFP or with siCAND1. After 48 h dif-
ferentiation was initiated by a hormone cocktail. After 1, 3 and 8 days of differentiation (corresponding to 3, 5 and 10 days after transfection) Western blots were performed with
indicated antibodies. CAND1 was clearly reduced by siCAND1 after 1 and 3 days of differentiation. However, after 8 days CAND1 steady state levels recovered to normal values in
cells transiently treated with siCAND1. Very similar dynamics were observed for the steady state levels of p27. (B) Quantiﬁcation of ORO staining was performed as described in
Materials and methods. Data are means±SEM of 3–4 independent experiments. Unpaired Student's t-test revealed statistical signiﬁcance of ORO staining reduction caused by
CAND1 silencing after 8 days (*Pb0.05). (C) Lipid droplet formation was analyzed by ORO staining using the Adipogenic differentiation kit after 1, 3 and 8 days of differentiation
in LiSa-2 cells treated with siGFP or with siCAND1. Microscopy was performed at 200-fold magniﬁcation.
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